Cargando...
Tubulin Inhibitor-Based Antibody-Drug Conjugates for Cancer Therapy
Antibody-drug conjugates (ADCs) are a class of highly potent biopharmaceutical drugs generated by conjugating cytotoxic drugs with specific monoclonal antibodies through appropriate linkers. Specific antibodies used to guide potent warheads to tumor tissues can effectively reduce undesired side effe...
Gardado en:
| Publicado en: | Molecules |
|---|---|
| Main Authors: | , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado: |
MDPI
2017
|
| Assuntos: | |
| Acceso en liña: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6152078/ https://ncbi.nlm.nih.gov/pubmed/28763044 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/molecules22081281 |
| Tags: |
Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!
|